Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Michael Yee upgraded ALX Oncology Holdings Inc. (NASDAQ:ALXO) from Hold to Buy and raised the price target from $2 to $3. ALX Oncology shares closed at $1.04 on Wednesday. See how other analysts view this stock.
- Seaport Global analyst Kenneth Zener upgraded D.R. Horton, Inc. (NYSE:DHI) …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Michael Yee upgraded ALX Oncology Holdings Inc. (NASDAQ:ALXO) from Hold to Buy and raised the price target from $2 to $3. ALX Oncology shares closed at $1.04 on Wednesday. See how other analysts view this stock.
- Seaport Global analyst Kenneth Zener upgraded D.R. Horton, Inc. (NYSE:DHI) …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Jefferies analyst Michael Yee upgraded ALX Oncology Holdings Inc. (NASDAQ:ALXO) from Hold to Buy and raised the price target from $2 to $3. ALX Oncology shares closed at $1.04 on Wednesday. See how other analysts view this stock.
Seaport Global analyst Kenneth Zener upgraded D.R. Horton, Inc. (NYSE:DHI) …Full story available on Benzinga.com Read MoreALXO, CUBE, DHI, FCX, News, top upgrades, ZS, Upgrades, Markets, Analyst Ratings, Trading Ideas, DHI, US23331A1097, FCX, US35671D8570, CUBE, ZS, ALXO, News, Upgrades, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
